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To determine whether exercise testing can identify pa-
tients whose survival might be prolonged by coronary
artery bypass surgery, the results of bypass surgery were
compared with those of medical therapy alone in 5,303
nonrandomized patients from the Coronary Artery Sur-
gery Study registry who underwent exercise testing. Pa-
tients in the two treatment groups differed substantially
with regard to important baseline variables. Analysis of
32 variables by Cox's regression model for survival re-
vealed an independent beneficial effect of bypass surgery
on survival (p < 0.00001). Patients were then stratified
into subsets according to the results of exercise testing.
Surgical benefit was greatest in the 789 patients who
exhibited at least 1 mm of ST segment depression and
The role of exercise testing in identifying patients with coro-
nary artery disease who are at a higher risk of dying has
been documented in many studies (1-8), including a report
from the Coronary Artery Surgery Study (CASS) patient
registry (9). Once identified, such patients are considered
to be prime candidates for coronary bypass surgery in the
hope of prolonging life; however, this potential benefit has
not been well studied. Results from the Seattle Heart Watch
Study (10), a nonrandomized trial, and the European Coro-
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who could exercise only into stage 1 or less. Among the
398 patients with three vessel coronary disease showing
these characteristics, 7 year survival was 58% for the
medical group and 81% for the surgical group (p <
0.001). There was no difference in survival between the
surgical and medical groups among the 1,545 patients
without ischemic ST segment depression who were able
to exercise into stage 3 or greater. Thus, in patients who
demonstrate ischemia on exercise testing and whose ex-
ercise capacity is limited, coronary bypass surgery ap-
pears to improve survival in comparison with medical
therapy alone.
(J Am Coli CardioI1986;8:741-8)
nary Surgery Study (II) suggested that bypass surgery in
patients with marked exercise abnormalities does prolong
survival, but these studies were limited by small numbers
of patients.
The goal of our study was to compare the influence of
surgical and medical therapy on coronary artery disease in
subgroups of patients based on the results of exercise testing.
To overcome the limitations inherent in small samples, we
analyzed the data from the CASS registry.
Methods
Study group. Details of the design, study protocol, qual-
ity control methods and the baseline data of the participating
patients in the CASS registry have been previously reported
(12). The CASS registry contains consecutive patients with
suspected or proved coronary artery disease who were re-
ferred to the 15 cooperating centers for cardiac catheteriza-
tion. Although exercise testing was not mandatory for re-
gistry patients, it was encouraged, and the results were
recorded when available. This study is based on an analysis
of 5,303 registry patients with no previous coronary bypass
surgery who underwent graded treadmill exercise testing
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using the standard or modified Bruce protocol (13) between
1974 and 1979 at one of the participating institutions within
I month of catheterization.
Study protocol. The following information was col-
lected prospectively on each patient and recorded on stan-
dardized forms: a clinical profile, data from physical ex-
amination and laboratory studies, exercise test results, chest
X-ray findings, precise angiographic characterization of the
coronary arteries and left ventricle, electrocardiographic
findings and information on surgical procedures (if appli-
cable). All patients were followed up at yearly intervals for
a minimum of 4 years to ascertain health status. Overall,
the follow-up was 99% complete.
Selective coronary arteriograms were obtained in mul-
tiple projections with either the brachial or femoral artery
technique. Clinically important coronary artery disease was
defined as 70% or greater narrowing of the diameter in either
the left anterior descending, left circumflex or right coronary
artery or their major branches or 50% or greater stenosis of
the left main segment. Left ventriculography was performed
using a single plane adaptation of the area-length method,
and the ejection fraction was determined from the right
anterior oblique projection (14). In addition, a left ventric-
ular contraction score (range 5 to 30) was calculated on the
basis of a subjective grading of the left ventricular angio-
gram as described previously (12).
The noninvasive and invasive data analyzed in this study
consisted of 18 clinical or historic variables, 8 variables
obtained from the exercise test and 5 obtained from cardiac
catheterization as delineated in Table I and described pre-
viously in detail (12). The variables were selected because
they were thought to be related to survival on the basis of
clinical judgment or previous publications.
Statistical methods and definitions. Univariate analysis
of categoric variables was performed using the chi-square
test. Quantitative variables were analyzed by using the Stu-
dent's t test. Cumulative survival curves were calculated
with the life table method and compared by the log-rank
statistic (15). A Cox proportional hazards model was used
to determine the significance of additional variables in the
survival analysis (16).
Because the patients were not randomized in this registry
study, the decision to treat a patient with medical or surgical
therapy was at the discretion of the physicians caring for
the patient. To compare the survival between the surgically
and medically treated patients, a statistical approach pre-
viously described in other CASS registry studies was used
(17,18). To avoid the problems of "crossovers" of medical
patients into the surgical group, surgical patients were de-
fined as those undergoing bypass surgery within a site-spe-
cific time frame during which 95% of the patients operated
on at a particular site within the first year had their operation.
This time period at the 15 participating institutions averaged
126 (range 90 to 240) days. All other patients belonged to
Table 1. Baseline Variables Analyzed
Clinical
Gender
Age
Chest pain
Description (definite angina. probable angina, nonischemic chest pain,
none)
Severity (I to V)
Congestive heart failure
History
Functional impairment (none, mild, moderate, severe)
Rales by examination
Cardiac enlargement
Score (0 to 4)*
Family history of coronary disease
History of hypertension
Previous myocardial infarction
Risk factor index
Previous cardiac arrest
Drug therapy
Digitalis
Diuretics
Beta-adrenergic blockade
No. of associated illnesses (0 to 5)t
Exercise test
Limiting symptom
Angina
Ventricular arrhythmias
Peak heart rate
Peak systolic blood pressure
Baseline ST segment on rest electrocardiogram
ST segment response
Final exercise stage
Catheterization
Number of stenotic coronary vessels ~70%
Left ventricular score (5 to 30):j:
Left ventricular ejection fraction
Left main coronary disease ~50% luminal stenosis
Left ventricular end-diastolic pressure
*One point was assigned for each of the following factors: history of
heart failure, use of digitalis, use of diuretics and presence of pulmonary
rales or an S3 gallop on auscultation. tOne point was assigned for each
of the following factors: diabetes mellitus, hypertension, cerebrovascular
disease, peripheral vascular disease and chronic pulmonary disease. :j:A
wall motion score for each of five different segments of the left ventricular
silhouette was calculated as follows: I = normal; 2 = mild hypokinesia;
3 = moderate hypokinesia; 4 = akinesia; 5 = dyskinesia; 6 = aneurysm.
the medical group. To compensate for the fact that the
medically treated patients are at risk for mortality earlier
than the surgically treated patients, the start of exposure for
the medically treated patients was determined by the average
number of days from enrollment to operation in the surgical
group (17,18).
Results
Baseline characteristics. The distribution of baseline
characteristics of the 3,660 medically treated and 1,643
surgically treated patients is shown in Table 2. The medi-
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Table 2. Baseline Characteristics of the Medical and Surgical Cohort
743
Medical Surgical
Variable (n = 3,660) (n = 1,643)
Clinical
Age <60 yr 3,126 (85%) 1,284 (78%)
Male gender 2,708 (74%) 1,451 (87%)
Congestive heart failure score ;::,3 114 ( 3%) 37 ( 2%)
Angina class III or IV 600 (16%) 635 (39%)
Prior myocardial infarction 1,612 (44%) 862 (53%)
One or more associated illnesses 2,707 (74%) 1,232 (75%)
Drug therapy
Digitalis 375 (10%) 163 (10%)
f3-adrenergic blocking agents [,325 (26%) 812 (49%)
Arteriographic
One vessel disease 913 (25%) 295 (18%)
Two vessel disease 639 (18%) 555 (34%)
Three vessel disease 479 (13%) 779 (47%)
Hemodynamic
Left ventricular score ;::, 10 588 (16%) 304 (19%)
Left ventricular end-diastolic 465 (13%) 282 (17%)
pressure ;::, 18
Exercise test
ST depression ;::, I mm 1,295 (35%) 1,020 (62%)
Final exercise stage :5 I 762(21%) 673 (41%)
Angina 963 (26%) 1,019 (62%)
p Value
<0,0001
<0,0001
0.259
<0.0001
<0.0001
0.115
0.721
<0.0001
<0.0001
<0.001
<0.001
<0.0001
<0.0001
<0.0001
cally treatedpatientshad less severeangina; theywereyoun-
ger and more of them were women. The surgically treated
patients had a higher prevalence of prior myocardial in-
farction, three vessel coronary artery disease and left ven-
tricular dysfunction. As a group, the surgical patients also
had more abnormal exercise test responses as characterized
by a greaterprevalenceof ischemic5T segmentdepression,
limited exercise capacity and exercise-induced angina. There
were no importantdifferences between the two groupswith
regardtootherassociated medical illnesses,congestive heart
failure score or the use of digitalis therapy.
During follow-up, 385 medically treated and 179 sur-
gically treated patients died. Eighty-one percent of the deaths
were reported to be either sudden « 1 hour) or cardiovas-
cular related.
Predictors of survival byregression analysis. The Cox
proportional hazards model was used to analyze and adjust
for those factors influencing survival in addition to exam-
Table 3. Predictors of Survival by Multivariate Analysis
Beta- 95% Chi-
Covariate Coefficient Confidence Limits Square p Value
Clinical and exercise
Congestive heart failure score 0.55 0.44, 0.68 256.8 0.00001
Prior myocardial infarction 0.42 0.31, 0.54 83.7 0.00001
Final exercise stage -0.24 - 0.32, - 0.17 51.3 0.00001
Gender -0.75 - 1.02, - 0.49 33.8 0.00001
Age 0.02 0.01, 0.03 14.7 0.0001
Treatment (medical or surgical) -0.35 -0.54, -0.17 13.8 0.0002
Illness count 0.11 0.04, 0.17 8.6 0.0033
Diuretic therapy -0.33 -0.60, -0.06 5.7 0.0171
Clinical, exercise and angiographic
Left ventricular score 0.12 0.09, 0.14 429.8 0.00001
Congestive heart failure score 0.27 0.18, 0.37 72.7 0.00001
No. of vessels diseased 0.37 0.27, 0.47 72.4 0.00001
Illness count 0.16 0.10, 0.23 27.3 0.00001
Treatment (medical or surgical) -0.53 -0.73, -0.33 27.2 0.00001
Left ventricular end-diastolic pressure 0.03 0.02, 0.04 21.1 0.00001
Final exercise stage -0.15 -0.23, -0.07 16.2 0.0001
Age 0.01 0.01, 0.03 9.6 0.0020
Gender -0.32 -0.61, -0.05 5.3 0.0211
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Figure 2. Cumulative survival rates in the surgical and medical
groups according to the amount of ST segment depression during
exercise testing.
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ining the effect of medical and surgical treatment. Analyses
by the Cox modelusing the clinical data alone were followed
next by the addition of the exercise variables, and finally
by the catheterization data. The results in Table 3 show a
marked impact on survival by the presence of congestive
heart failure and a prior myocardial infarction, the final
exercise stage achieved, left ventriculardysfunctionand the
number of diseased coronary vessels; however, an inde-
pendent beneficial effect of surgical therapy was also doc-
umented.
Predictors of survival by individual exercise test vari-
ables: medical versus surgical. The cumulative 7 year
survival, unadjusted for differences in prognostic factors
between the two groups, was similarfor the medically treated
(86%) and the surgically treated (85%) patients (Fig. I).
Survival rates in the medical and surgical groups were then
calculated according to the results of the exercise test (Fig.
2 to 4). When patients weregroupedaccordingto the amount
of ST segmentdepressionduring exercise testing, those with
less than I mm of ST segment depression had a slightly
better 7 year survival rate with medical therapy (89 versus
83%, p = 0.03), whereas among patients with I to 2 mm
or greater ST segment depression, the 7 year survival rate
was significantly higher in those treated surgically (Fig. 2).
The patients were then grouped according to the final ex-
ercise stage of the Bruce protocol achieved. For those pa-
tients limited to stage I or less of exercise, surgery resulted
in a slight survival advantage at 7 years (81 versus 78%,
p = 0.04), whereas for patients able to exercise into stage
2 or greater, survival rates were similar with medical and
surgical therapy (Fig. 3).
Predictors of survival by exercise risk classification:
medical versus surgical. The two individual exercise vari-
ables, ST segment response and final exercise stageachieved,
were then combined into an exercise risk classification. The
Figure 1. Cumulative survival rates for all patients in the surgical
and medical groups undergoing exercise testing. The log-rank sta-
tistic, with itscorresponding p value. tests for statistically different
survival patterns among the individual groups. N = number of
patients.
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lower risk subsetcomprised 1,545patients without ischemic
ST segment depression who could exercise into stage 3 or
greater. The 7 year survival rates for the medical and sur-
gical cohorts were virtually identical (Fig. 4). The higher
risk subset encompassed789 patients who exhibited at least
I mm of ST segment depression and who could exercise
only intostage I or less. Incontrast to the lowerrisksubgroup.
the 7 year survival rate for this subset was substantially
improved with surgical compared with medical treatment
(82 versus 72%. respectively, p == 0.001).
Survival by exercise risk classification stratified for
vessels diseased and left ventricular score. To delineate
the relative importance of this exercise classification to an-
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risk exercise classification, however, there was no differ-
ence in 6 year survival between the medical and surgical
cohorts (83 versus 88%, respectively; p = 0.31). For pa-
tients with no or minimal left ventricular dysfunction (scores
:::::9), survival rates were similar for the medical and surgical
patients with a higher risk exercise classification (Fig. 6).
For patients with more severe left ventricular dysfunction
(scores:?: 10), the 7 year survival rate was significantly better
for the surgical than for the medical cohort (67 versus 49%,
p = 0.005).
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Figure 4. Cumulative survival rates for the medical and surgical
patients according to the exercise risk classification. A lower risk
subgroup comprised patients with less than I mm ST segment
depression and a final exercise stage of 3 or higher, whereas a
higher risk subgroup consisted of patients with I mm or greater
ST segment depression and a final exercise stage of I or less.
The therapeutic decision to recommend medical treat-
ment or surgical revascularization for patients with angina
pectoris varies among physicians. Although coronary bypass
surgery has been shown to result in greater symptomatic
relief from angina compared with medical therapy, in only
a few subsets of patients has surgery been shown to result
o
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Figure 3. Cumulative survival rates in the surgical and medical
groups based on the final exercise stage.
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giographic information, life table analyses were performed
stratifying for left ventricular function and extent of coro-
nary disease. For the 114 patients with one vessel disease
and for the 210 patients with two vessel disease, 7 year
survival rates were not different for those patients in the
higher risk exercise classification treated medically or sur-
gically (Fig. 5). In the 398 patients with three vessel disease
in the higher risk exercise classification, however, there was
a marked difference between the 7 year survival rates: 81%
for the surgical and 58% for the medical group (p < 0.0001).
In the 137 patients with three vessel disease and in a lower
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Figure 6. Cumulative survival rates for medical and surgical pa-
tients with the higher risk exercise classification and preserved
(score :S 9) or impaired (score ~ 10) left ventricular (LV) function.
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risk exercise classification) was a potent predictor of patients
whose survival would be improved with bypass surgery.
These findings may be stronger in light of the major dif-
ferences in baseline variables between the two treatment
groups because a higher prevalence of the prognostic vari-
ables associated with poor survival was found in the surgical
cohort.
Surgical versus medical therapy in high risk exercise
classification. Furthermore, stratification of patients based
on the most important prognostic angiographic variables
revealed that coronary bypass surgery was associated with
improved survival in patients with the higher risk exercise
classification who also had three vessel coronary artery dis-
ease or impaired left ventricular function. Among patients
with three vessel coronary disease, there have been con-
flicting reports of the benefit of bypass surgery on survival.
In the CASS randomized trial (20), bypass surgery pro-
longed survival in patients with three vessel coronary disease
and a low ejection fraction, whereas in the European Coro-
nary Surgery Study (11), also a randomized trial, survival
was prolonged by surgery in all patients with three vessel
disease. In our present analysis on observational data, sur-
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in a better survival (19,20). The use of exercise testing to
identify patients at higher risk whose survival might be
enhanced by surgery has been suggested by some studies
but the conclusions were limited because of the small num-
ber of patients studied (10,11).
Surgical versus medical therapy based on exercise test
results. In our study, coronary bypass surgery appeared to
offer a modest survival advantage for patients who had at
least 1 mm of ST segment depression during exercise testing
or who could exercise only into stage I or less of the Bruce
protocol. The combination of these two variables (our higher
P < .0001
Lov Rank lIlal - 24,578
Figure 5. Cumulative survival rates for medical and surgical pa-
tients with the higher risk exercise classification and single, double
or triple vessel coronary disease.
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gery prolonged survival for patients with three vessel disease
only among those showing a higher risk exercise classifi-
cation. This subgroup represented 32% of the patients with
three vessel disease in our study. In the patients with two
vessel disease and a higher risk exercise classification, there
was a widening trend in favor of surgery at 5 to 7 years,
but this difference was not statistically significant (Fig. 5).
Surgical versus medical therapy in the lower risk ex-
ercise classification. Our results have also identified a lower
risk subgroup. Those patients who showed less than I mm
of ST segment depression and exercised into stage 3 or more
of the Bruce protocol constituted 38% of our population and
had an annual mortality rate of 1.3%. Coronary bypass
surgery did not improve survival in this lower risk subset,
even in the patients with three vessel coronary artery disease.
Comparison with previous studies. Our results are in
agreement with reports from other trials in which exercise
testing was used to identify patients whose survival was
enhanced by bypass surgery. In the Seattle Heart Watch
Study (10), the surgical cohort of patients with noninvasive
evidence of left ventricular dysfunction (either cardiomeg-
aly, a duration of exercise less than 3 minutes or a peak
systolic blood pressure less than 130 mm Hg) had a sig-
nificantly improved survival at 4 years compared with pa-
tients in the medical cohort with these characteristics (94
versus 67%, respectively; p < 0.001). The European Coro-
nary Surgery Study (II) showed a survival advantage for
the surgically assigned patients who had at least 1.5 mm of
ischemic ST depression during exercise testing. Finally, a
recent report (21) from the CASS randomized trial docu-
mented that the occurrence of angina during exercise testing
was a potent marker for those patients who would live longer
after coronary bypass surgery, but this advantage was re-
stricted to patients with three vessel disease and impaired
left ventricular function. The analysis from the randomized
trial did not find that other exercise variables aided in risk
classification, as we found in the present study. It is likely
that the differing results are related to the different popu-
lations studied and the smaller numbers of patients in the
randomized cohort.
Limitations of study. This study was performed in a
large, prospectively followed series of consecutive patients
from the CASS registry and represents the largest number
of patients analyzed with complete exercise test and angio-
graphic results. Nevertheless, the evaluation of observa-
tional data using the statistical techniques employed has
limitations when compared with randomization (22,23). The
decision to recommend medical or surgical therapy may
have been based on characteristics not used in our analysis.
The use of the Cox proportional hazards model to account
for baseline differences between the two groups and the
stratification of patients into angiographic subgroups would
tend to reduce the bias of a nonrandomized study design.
Another important consideration in the analysis of nu-
merous subgroups is the problem of multiple comparisons
that may result in an occasional "significant" difference
between groups on the basis of chance (24). A probability
of 0.01 would be a conservative estimate of a significant
difference between subgroups based on the number of anal-
yses performed in our study (25).
Conclusions. Our results indicate that exercise testing
is a useful method to stratify the risk of patients suspected
of having coronary artery disease. This classification is help-
ful not only in identifying subsets of patients whose survival
is enhanced by coronary bypass surgery but also in char-
acterizing a subgroup of patients with excellent survival
when treated medically.
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